Search Results 1561-1570 of 14984 for Hepatitis C

1. A Study to Evaluate the Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer - Mayo Clinic

   ... Hepatitis C (e.g., HCV RNA [qualitative] is detected). In patients without a known history of Hepatitis B or C, serologies should be obtained at screening.

2. Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant - Mayo Clinic

   Known or suspected active hepatitis C infection. Any medical or psychiatric illness that could, in the investigator's opinion, potentially interfere with ...

3. Oral AMXT 1501 Dicaprate in Combination With IV DFMO - Mayo Clinic

   ... C). Limited prior palliative ... Current active liver disease from any cause, including hepatitis A (hepatitis A virus immunoglobulin M positive), hepatitis ...

4. Fatigue - Mayo Clinic

   Hepatitis B and Hepatitis C: What's the difference? Hepatitis C · Hepatitis C: What happens in end-stage liver disease? Herbal treatment for anxiety: Is it ...

5. A Study Evaluating The Safety, Tolerability, Preliminary Drug/Body Interactions And Biological Activity Of MYK-461 - Mayo Clinic

   ... hepatitis C virus (HCV) or hepatitis B virus (HBV). Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the ...

6. A Study To Assess The Effectiveness And Safety Of Rilonacept Treatment In Subjects With Recurrent Pericarditis - Mayo Clinic

   Has a history of positive or intermediate results for hepatitis B surface antigen, hepatitis B core antibody, or hepatitis C virus antibody at screening.

7. A Study To Investigate The Effectiveness And Safety Of Injectafer For The Treatment Of Restless Legs Syndrome - Mayo Clinic

   Known positive hepatitis B antigen (HBsAg) or hepatitis C viral antibody (HCV) with evidence of active hepatitis (i.e., AST/ALT greater than the upper limit of ...

8. A Study of DCC-2618 vs. Sunitinib in Advanced GIST Patients after Treatment with Imatinib - Mayo Clinic

   ... hepatitis B, or active hepatitis C infection. If female, the patient is pregnant or lactating. Known allergy or hypersensitivity to any component of the ...

9. Efficacy And Safety Of Nemtabrutinib (MK-1026) In Participants With Hematologic Malignancies (MK-1026-003) - Mayo Clinic

   * Participants with history of Hepatitis C virus (HCV) infection are eligible if HCV viral load is undetectable at screening * Has adequate organ function * ...

10. Publications - Sushil Kumar Garg, M.B.B.S. - Mayo Clinic

    Sarvepalli S, Garg SK, Sarvepalli SS, Anugwom C, Wadhwa V, Thota PN, Sanaka MR. ... Extra-hepatic manifestations associated with hepatitis E virus infection: a ...